圈哥喜大普奔:最左光正主流假媒体time报道最低级期刊NEJM研究:Data Doesn’t Support New COVID-19 Booster Shots for Most

billwanhua

本站元老
注册
2005-07-07
消息
15,318
荣誉分数
4,775
声望点数
373

In a perspective published Jan. 11 in the New England Journal of Medicine, vaccine expert Dr. Paul Offit says it’s time to rethink booster recommendations.

In the third year of the pandemic, the population’s immune situation is vastly different from what it was in 2019 when SARS-CoV-2 emerged. Now, most people have been vaccinated against the virus, been infected with it (once or multiple times), or both. And the latest data show that the newest booster shot, which targets the Omicron BA.4/5 strain and original virus variants in a bivalent formulation, isn’t that much more effective in generating virus-fighting antibodies than the original vaccine when used as a booster.

But COVID-19, and the population’s ability to combat it, has changed since then. For one, the variant of the virus now infecting people—XBB.1.5—is different from the original. Through a combination of the fact that many people now have higher levels of protection from vaccines or having recovered from infections, and the fact that the Omicron variants as a group, BA.4/5 and XBB.1.5 included, do not seem to cause serious disease in most healthy people, the job of booster doses has also evolved. Now, boosting everyone with an Omicron shot is “trying to prevent, in otherwise healthy people, mild illness for a few months,” says Offit, until the next variant comes along to replace it. “That doesn’t make sense.”
“试图防止健康的人得小病几个月”
最后一句就是蔡桓公说的: 医之好治不病以为功

那些强烈呼吁土鳖引进mRNA疫苗的出来辩护一下
 
最后编辑:
神药需要空间,疫苗赶紧撤. 市场规律.
 
艾棣维欣生物执行董事、董事会副主席张璐楠表示:“从免疫学的角度,同一种疫苗打的次数多了,免疫系统可能会对疫苗钝化,这时候需要别的技术路线的疫苗来加强。所以很可能会出现第二次序贯、第三次序贯,最终会把各个技术路线的疫苗都轮番加强免疫,起到增强效果的作用。不同的技术路线,可以对人体的免疫系统产生不同角度的激活,是一个必要的补充。”

同一种疫苗打多了出现疫苗钝化?对疫苗麻木不仁


中国每个疫苗厂家来一针,大家一起赚?
 
后退
顶部